CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

CMG Pharmaceutical Revenue

CMG Pharmaceutical had revenue of 25.52B KRW in the quarter ending March 31, 2026, with 23.71% growth. This brings the company's revenue in the last twelve months to 110.12B, up 13.63% year-over-year. In the year 2025, CMG Pharmaceutical had annual revenue of 105.23B with 6.19% growth.

• Revenue (ttm): 110.12B
• Revenue Growth: +13.63%
• P/S Ratio: 0.74
• Revenue / Employee: 493.81M
• Employees: 223
• Market Cap: 81.91B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	105.23B	6.13B	6.19%
Dec 31, 2024	99.10B	5.19B	5.53%
Dec 31, 2023	93.91B	11.71B	14.25%
Dec 31, 2022	82.20B	23.57B	40.21%
Dec 31, 2019	58.62B	8.76B	17.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error